TransMedics Group Inc (TMDX)
Activity ratios
Short-term
Turnover ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inventory turnover | 3.86 | 3.13 | 2.90 | 2.30 | 1.98 | 1.65 | 1.53 | 1.55 | 1.37 | 1.09 | 0.81 | 0.64 | 0.61 | 0.62 | 0.74 | 0.73 | 0.75 | 0.66 | 0.75 | 0.91 |
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Working capital turnover | 1.01 | 0.93 | 0.79 | 0.68 | 0.53 | 0.39 | 0.24 | 0.51 | 0.41 | 0.31 | 0.71 | 0.46 | 0.32 | 0.26 | 0.25 | 0.20 | 0.19 | 0.17 | 0.17 | 0.35 |
TransMedics Group Inc's Inventory turnover ratio has shown a positive trend over the past few years, indicating an improvement in the management of inventory. The ratio has steadily increased from 0.91 in March 2020 to 3.86 in December 2024, suggesting that the company is selling its inventory more efficiently.
The Receivables turnover and Payables turnover ratios are not available in the data provided, which hinders a complete assessment of the company's efficiency in collecting receivables and managing payables.
The Working Capital turnover ratio, on the other hand, has fluctuated over the years. It ranged from 0.17 in June 2020 to 1.01 in December 2024. A higher turnover ratio indicates that the company is generating more revenue relative to its working capital, which can be a positive sign of operational efficiency.
In conclusion, while the inventory turnover ratio has shown improvement, the lack of data for receivables and payables turnover ratios limits a full assessment of TransMedics Group Inc's efficiency in managing these aspects of its operations.
Average number of days
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | 94.58 | 116.57 | 125.86 | 158.57 | 184.46 | 221.21 | 238.47 | 235.11 | 266.82 | 335.69 | 448.18 | 573.53 | 595.80 | 588.63 | 490.65 | 503.07 | 483.77 | 556.17 | 484.57 | 402.29 |
| Days of sales outstanding (DSO) | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Number of days of payables | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
TransMedics Group Inc's Days of Inventory on Hand (DOH) ratio reflects the number of days the company holds its inventory before it is sold. The trend in this ratio shows a significant decline from 402.29 days on March 31, 2020, to 94.58 days on December 31, 2024. This indicates that the company has been able to manage its inventory more efficiently over the years, potentially reducing carrying costs and improving cash flow.
However, data on Days of Sales Outstanding (DSO) and Number of Days of Payables were not provided, so we are unable to assess the efficiency of the company in collecting receivables and paying its liabilities. It would be beneficial to have this information to get a complete picture of TransMedics Group Inc's activity ratios and overall working capital management.
Long-term
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fixed asset turnover | — | — | — | — | — | — | 5.62 | 6.22 | 3.84 | 3.88 | 3.18 | 3.25 | 1.93 | 5.57 | 6.04 | 5.32 | 5.39 | 5.13 | 5.49 | 5.61 |
| Total asset turnover | 0.55 | 0.51 | 0.47 | 0.41 | 0.34 | 0.28 | 0.22 | 0.41 | 0.34 | 0.26 | 0.44 | 0.32 | 0.22 | 0.22 | 0.21 | 0.17 | 0.17 | 0.15 | 0.15 | 0.27 |
The fixed asset turnover ratio measures how efficiently a company is utilizing its fixed assets to generate revenue. A higher ratio indicates better utilization of fixed assets.
For TransMedics Group Inc, the fixed asset turnover ratio shows some fluctuations over the years. It was relatively stable around 5.0 in the period from March 2020 to September 2021. However, there was a significant drop to 1.93 by December 2021, indicating a decrease in the efficiency of using fixed assets to generate revenue. Subsequently, the ratio improved slightly but remained below the previous levels through 2022.
In March 2023, there was a notable increase in the fixed asset turnover ratio to 6.22, suggesting a significant improvement in utilizing fixed assets efficiently to generate sales. This improvement continued through the following quarters in 2023, indicating better management of fixed assets for revenue generation.
However, from 2024 onward, the data is not provided for the fixed asset turnover ratio. It is important to note that a consistently high or increasing fixed asset turnover ratio reflects positively on the company's operational efficiency and utilization of assets in revenue generation.